The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Guaiphenesin Market Research Report 2024
Synopsis
Guaiphenesin is also known as Guaifenesin is an expectorant drug usually taken orally to assist the expectoration ('bringing up') of phlegm from the airways in acute respiratory tract infections.
The global Guaiphenesin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Guaiphenesin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Guaiphenesin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Guaiphenesin in Chronic Bronchitis With Phlegm is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Guaiphenesin include EMS Pharmaceutical, Mission Pharma, Orbis Biosciences, Sovereign Pharma, Lipocine Inc, Kowa, RB Pharma, Elan and Granules, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Guaiphenesin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Guaiphenesin.
Report Scope
The Guaiphenesin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Guaiphenesin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Guaiphenesin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
EMS Pharmaceutical
Mission Pharma
Orbis Biosciences
Sovereign Pharma
Lipocine Inc
Kowa
RB Pharma
Elan
Granules
Synthokem Labs
Haizhou Pharma
Prasco
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Smart Pharm
Silarx Pharmaceuticals
Meda Pharmaceuticals (Mylan)
Aurohealth LLC
Enzymatic Therapy
Seven Star Pharma
Segment by Type
Active Pharmaceutical Ingredients
Preparation
Segment by Application
Chronic Bronchitis With Phlegm
Bronchiectasis
Infection
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Guaiphenesin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Guaiphenesin is also known as Guaifenesin is an expectorant drug usually taken orally to assist the expectoration ('bringing up') of phlegm from the airways in acute respiratory tract infections.
The global Guaiphenesin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Guaiphenesin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Guaiphenesin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Guaiphenesin in Chronic Bronchitis With Phlegm is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Guaiphenesin include EMS Pharmaceutical, Mission Pharma, Orbis Biosciences, Sovereign Pharma, Lipocine Inc, Kowa, RB Pharma, Elan and Granules, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Guaiphenesin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Guaiphenesin.
Report Scope
The Guaiphenesin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Guaiphenesin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Guaiphenesin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
EMS Pharmaceutical
Mission Pharma
Orbis Biosciences
Sovereign Pharma
Lipocine Inc
Kowa
RB Pharma
Elan
Granules
Synthokem Labs
Haizhou Pharma
Prasco
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Smart Pharm
Silarx Pharmaceuticals
Meda Pharmaceuticals (Mylan)
Aurohealth LLC
Enzymatic Therapy
Seven Star Pharma
Segment by Type
Active Pharmaceutical Ingredients
Preparation
Segment by Application
Chronic Bronchitis With Phlegm
Bronchiectasis
Infection
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Guaiphenesin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Guaiphenesin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Active Pharmaceutical Ingredients
1.2.3 Preparation
1.3 Market by Application
1.3.1 Global Guaiphenesin Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Chronic Bronchitis With Phlegm
1.3.3 Bronchiectasis
1.3.4 Infection
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Guaiphenesin Market Perspective (2019-2030)
2.2 Guaiphenesin Growth Trends by Region
2.2.1 Global Guaiphenesin Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Guaiphenesin Historic Market Size by Region (2019-2024)
2.2.3 Guaiphenesin Forecasted Market Size by Region (2025-2030)
2.3 Guaiphenesin Market Dynamics
2.3.1 Guaiphenesin Industry Trends
2.3.2 Guaiphenesin Market Drivers
2.3.3 Guaiphenesin Market Challenges
2.3.4 Guaiphenesin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Guaiphenesin Players by Revenue
3.1.1 Global Top Guaiphenesin Players by Revenue (2019-2024)
3.1.2 Global Guaiphenesin Revenue Market Share by Players (2019-2024)
3.2 Global Guaiphenesin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Guaiphenesin Revenue
3.4 Global Guaiphenesin Market Concentration Ratio
3.4.1 Global Guaiphenesin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Guaiphenesin Revenue in 2023
3.5 Guaiphenesin Key Players Head office and Area Served
3.6 Key Players Guaiphenesin Product Solution and Service
3.7 Date of Enter into Guaiphenesin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Guaiphenesin Breakdown Data by Type
4.1 Global Guaiphenesin Historic Market Size by Type (2019-2024)
4.2 Global Guaiphenesin Forecasted Market Size by Type (2025-2030)
5 Guaiphenesin Breakdown Data by Application
5.1 Global Guaiphenesin Historic Market Size by Application (2019-2024)
5.2 Global Guaiphenesin Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Guaiphenesin Market Size (2019-2030)
6.2 North America Guaiphenesin Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Guaiphenesin Market Size by Country (2019-2024)
6.4 North America Guaiphenesin Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Guaiphenesin Market Size (2019-2030)
7.2 Europe Guaiphenesin Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Guaiphenesin Market Size by Country (2019-2024)
7.4 Europe Guaiphenesin Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Guaiphenesin Market Size (2019-2030)
8.2 Asia-Pacific Guaiphenesin Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Guaiphenesin Market Size by Region (2019-2024)
8.4 Asia-Pacific Guaiphenesin Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Guaiphenesin Market Size (2019-2030)
9.2 Latin America Guaiphenesin Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Guaiphenesin Market Size by Country (2019-2024)
9.4 Latin America Guaiphenesin Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Guaiphenesin Market Size (2019-2030)
10.2 Middle East & Africa Guaiphenesin Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Guaiphenesin Market Size by Country (2019-2024)
10.4 Middle East & Africa Guaiphenesin Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 EMS Pharmaceutical
11.1.1 EMS Pharmaceutical Company Detail
11.1.2 EMS Pharmaceutical Business Overview
11.1.3 EMS Pharmaceutical Guaiphenesin Introduction
11.1.4 EMS Pharmaceutical Revenue in Guaiphenesin Business (2019-2024)
11.1.5 EMS Pharmaceutical Recent Development
11.2 Mission Pharma
11.2.1 Mission Pharma Company Detail
11.2.2 Mission Pharma Business Overview
11.2.3 Mission Pharma Guaiphenesin Introduction
11.2.4 Mission Pharma Revenue in Guaiphenesin Business (2019-2024)
11.2.5 Mission Pharma Recent Development
11.3 Orbis Biosciences
11.3.1 Orbis Biosciences Company Detail
11.3.2 Orbis Biosciences Business Overview
11.3.3 Orbis Biosciences Guaiphenesin Introduction
11.3.4 Orbis Biosciences Revenue in Guaiphenesin Business (2019-2024)
11.3.5 Orbis Biosciences Recent Development
11.4 Sovereign Pharma
11.4.1 Sovereign Pharma Company Detail
11.4.2 Sovereign Pharma Business Overview
11.4.3 Sovereign Pharma Guaiphenesin Introduction
11.4.4 Sovereign Pharma Revenue in Guaiphenesin Business (2019-2024)
11.4.5 Sovereign Pharma Recent Development
11.5 Lipocine Inc
11.5.1 Lipocine Inc Company Detail
11.5.2 Lipocine Inc Business Overview
11.5.3 Lipocine Inc Guaiphenesin Introduction
11.5.4 Lipocine Inc Revenue in Guaiphenesin Business (2019-2024)
11.5.5 Lipocine Inc Recent Development
11.6 Kowa
11.6.1 Kowa Company Detail
11.6.2 Kowa Business Overview
11.6.3 Kowa Guaiphenesin Introduction
11.6.4 Kowa Revenue in Guaiphenesin Business (2019-2024)
11.6.5 Kowa Recent Development
11.7 RB Pharma
11.7.1 RB Pharma Company Detail
11.7.2 RB Pharma Business Overview
11.7.3 RB Pharma Guaiphenesin Introduction
11.7.4 RB Pharma Revenue in Guaiphenesin Business (2019-2024)
11.7.5 RB Pharma Recent Development
11.8 Elan
11.8.1 Elan Company Detail
11.8.2 Elan Business Overview
11.8.3 Elan Guaiphenesin Introduction
11.8.4 Elan Revenue in Guaiphenesin Business (2019-2024)
11.8.5 Elan Recent Development
11.9 Granules
11.9.1 Granules Company Detail
11.9.2 Granules Business Overview
11.9.3 Granules Guaiphenesin Introduction
11.9.4 Granules Revenue in Guaiphenesin Business (2019-2024)
11.9.5 Granules Recent Development
11.10 Synthokem Labs
11.10.1 Synthokem Labs Company Detail
11.10.2 Synthokem Labs Business Overview
11.10.3 Synthokem Labs Guaiphenesin Introduction
11.10.4 Synthokem Labs Revenue in Guaiphenesin Business (2019-2024)
11.10.5 Synthokem Labs Recent Development
11.11 Haizhou Pharma
11.11.1 Haizhou Pharma Company Detail
11.11.2 Haizhou Pharma Business Overview
11.11.3 Haizhou Pharma Guaiphenesin Introduction
11.11.4 Haizhou Pharma Revenue in Guaiphenesin Business (2019-2024)
11.11.5 Haizhou Pharma Recent Development
11.12 Prasco
11.12.1 Prasco Company Detail
11.12.2 Prasco Business Overview
11.12.3 Prasco Guaiphenesin Introduction
11.12.4 Prasco Revenue in Guaiphenesin Business (2019-2024)
11.12.5 Prasco Recent Development
11.13 Camlin Fine Science
11.13.1 Camlin Fine Science Company Detail
11.13.2 Camlin Fine Science Business Overview
11.13.3 Camlin Fine Science Guaiphenesin Introduction
11.13.4 Camlin Fine Science Revenue in Guaiphenesin Business (2019-2024)
11.13.5 Camlin Fine Science Recent Development
11.14 Gennex Lab
11.14.1 Gennex Lab Company Detail
11.14.2 Gennex Lab Business Overview
11.14.3 Gennex Lab Guaiphenesin Introduction
11.14.4 Gennex Lab Revenue in Guaiphenesin Business (2019-2024)
11.14.5 Gennex Lab Recent Development
11.15 Iwaki Seiyaku
11.15.1 Iwaki Seiyaku Company Detail
11.15.2 Iwaki Seiyaku Business Overview
11.15.3 Iwaki Seiyaku Guaiphenesin Introduction
11.15.4 Iwaki Seiyaku Revenue in Guaiphenesin Business (2019-2024)
11.15.5 Iwaki Seiyaku Recent Development
11.16 Pan Drugs
11.16.1 Pan Drugs Company Detail
11.16.2 Pan Drugs Business Overview
11.16.3 Pan Drugs Guaiphenesin Introduction
11.16.4 Pan Drugs Revenue in Guaiphenesin Business (2019-2024)
11.16.5 Pan Drugs Recent Development
11.17 Smart Pharm
11.17.1 Smart Pharm Company Detail
11.17.2 Smart Pharm Business Overview
11.17.3 Smart Pharm Guaiphenesin Introduction
11.17.4 Smart Pharm Revenue in Guaiphenesin Business (2019-2024)
11.17.5 Smart Pharm Recent Development
11.18 Silarx Pharmaceuticals
11.18.1 Silarx Pharmaceuticals Company Detail
11.18.2 Silarx Pharmaceuticals Business Overview
11.18.3 Silarx Pharmaceuticals Guaiphenesin Introduction
11.18.4 Silarx Pharmaceuticals Revenue in Guaiphenesin Business (2019-2024)
11.18.5 Silarx Pharmaceuticals Recent Development
11.19 Meda Pharmaceuticals (Mylan)
11.19.1 Meda Pharmaceuticals (Mylan) Company Detail
11.19.2 Meda Pharmaceuticals (Mylan) Business Overview
11.19.3 Meda Pharmaceuticals (Mylan) Guaiphenesin Introduction
11.19.4 Meda Pharmaceuticals (Mylan) Revenue in Guaiphenesin Business (2019-2024)
11.19.5 Meda Pharmaceuticals (Mylan) Recent Development
11.20 Aurohealth LLC
11.20.1 Aurohealth LLC Company Detail
11.20.2 Aurohealth LLC Business Overview
11.20.3 Aurohealth LLC Guaiphenesin Introduction
11.20.4 Aurohealth LLC Revenue in Guaiphenesin Business (2019-2024)
11.20.5 Aurohealth LLC Recent Development
11.21 Enzymatic Therapy
11.21.1 Enzymatic Therapy Company Detail
11.21.2 Enzymatic Therapy Business Overview
11.21.3 Enzymatic Therapy Guaiphenesin Introduction
11.21.4 Enzymatic Therapy Revenue in Guaiphenesin Business (2019-2024)
11.21.5 Enzymatic Therapy Recent Development
11.22 Seven Star Pharma
11.22.1 Seven Star Pharma Company Detail
11.22.2 Seven Star Pharma Business Overview
11.22.3 Seven Star Pharma Guaiphenesin Introduction
11.22.4 Seven Star Pharma Revenue in Guaiphenesin Business (2019-2024)
11.22.5 Seven Star Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Guaiphenesin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Active Pharmaceutical Ingredients
Table 3. Key Players of Preparation
Table 4. Global Guaiphenesin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Guaiphenesin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Guaiphenesin Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Guaiphenesin Market Share by Region (2019-2024)
Table 8. Global Guaiphenesin Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Guaiphenesin Market Share by Region (2025-2030)
Table 10. Guaiphenesin Market Trends
Table 11. Guaiphenesin Market Drivers
Table 12. Guaiphenesin Market Challenges
Table 13. Guaiphenesin Market Restraints
Table 14. Global Guaiphenesin Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Guaiphenesin Market Share by Players (2019-2024)
Table 16. Global Top Guaiphenesin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guaiphenesin as of 2023)
Table 17. Ranking of Global Top Guaiphenesin Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Guaiphenesin Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Guaiphenesin Product Solution and Service
Table 21. Date of Enter into Guaiphenesin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Guaiphenesin Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Guaiphenesin Revenue Market Share by Type (2019-2024)
Table 25. Global Guaiphenesin Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Guaiphenesin Revenue Market Share by Type (2025-2030)
Table 27. Global Guaiphenesin Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Guaiphenesin Revenue Market Share by Application (2019-2024)
Table 29. Global Guaiphenesin Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Guaiphenesin Revenue Market Share by Application (2025-2030)
Table 31. North America Guaiphenesin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Guaiphenesin Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Guaiphenesin Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Guaiphenesin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Guaiphenesin Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Guaiphenesin Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Guaiphenesin Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Guaiphenesin Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Guaiphenesin Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Guaiphenesin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Guaiphenesin Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Guaiphenesin Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Guaiphenesin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Guaiphenesin Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Guaiphenesin Market Size by Country (2025-2030) & (US$ Million)
Table 46. EMS Pharmaceutical Company Detail
Table 47. EMS Pharmaceutical Business Overview
Table 48. EMS Pharmaceutical Guaiphenesin Product
Table 49. EMS Pharmaceutical Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 50. EMS Pharmaceutical Recent Development
Table 51. Mission Pharma Company Detail
Table 52. Mission Pharma Business Overview
Table 53. Mission Pharma Guaiphenesin Product
Table 54. Mission Pharma Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 55. Mission Pharma Recent Development
Table 56. Orbis Biosciences Company Detail
Table 57. Orbis Biosciences Business Overview
Table 58. Orbis Biosciences Guaiphenesin Product
Table 59. Orbis Biosciences Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 60. Orbis Biosciences Recent Development
Table 61. Sovereign Pharma Company Detail
Table 62. Sovereign Pharma Business Overview
Table 63. Sovereign Pharma Guaiphenesin Product
Table 64. Sovereign Pharma Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 65. Sovereign Pharma Recent Development
Table 66. Lipocine Inc Company Detail
Table 67. Lipocine Inc Business Overview
Table 68. Lipocine Inc Guaiphenesin Product
Table 69. Lipocine Inc Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 70. Lipocine Inc Recent Development
Table 71. Kowa Company Detail
Table 72. Kowa Business Overview
Table 73. Kowa Guaiphenesin Product
Table 74. Kowa Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 75. Kowa Recent Development
Table 76. RB Pharma Company Detail
Table 77. RB Pharma Business Overview
Table 78. RB Pharma Guaiphenesin Product
Table 79. RB Pharma Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 80. RB Pharma Recent Development
Table 81. Elan Company Detail
Table 82. Elan Business Overview
Table 83. Elan Guaiphenesin Product
Table 84. Elan Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 85. Elan Recent Development
Table 86. Granules Company Detail
Table 87. Granules Business Overview
Table 88. Granules Guaiphenesin Product
Table 89. Granules Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 90. Granules Recent Development
Table 91. Synthokem Labs Company Detail
Table 92. Synthokem Labs Business Overview
Table 93. Synthokem Labs Guaiphenesin Product
Table 94. Synthokem Labs Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 95. Synthokem Labs Recent Development
Table 96. Haizhou Pharma Company Detail
Table 97. Haizhou Pharma Business Overview
Table 98. Haizhou Pharma Guaiphenesin Product
Table 99. Haizhou Pharma Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 100. Haizhou Pharma Recent Development
Table 101. Prasco Company Detail
Table 102. Prasco Business Overview
Table 103. Prasco Guaiphenesin Product
Table 104. Prasco Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 105. Prasco Recent Development
Table 106. Camlin Fine Science Company Detail
Table 107. Camlin Fine Science Business Overview
Table 108. Camlin Fine Science Guaiphenesin Product
Table 109. Camlin Fine Science Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 110. Camlin Fine Science Recent Development
Table 111. Gennex Lab Company Detail
Table 112. Gennex Lab Business Overview
Table 113. Gennex Lab Guaiphenesin Product
Table 114. Gennex Lab Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 115. Gennex Lab Recent Development
Table 116. Iwaki Seiyaku Company Detail
Table 117. Iwaki Seiyaku Business Overview
Table 118. Iwaki Seiyaku Guaiphenesin Product
Table 119. Iwaki Seiyaku Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 120. Iwaki Seiyaku Recent Development
Table 121. Pan Drugs Company Detail
Table 122. Pan Drugs Business Overview
Table 123. Pan Drugs Guaiphenesin Product
Table 124. Pan Drugs Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 125. Pan Drugs Recent Development
Table 126. Smart Pharm Company Detail
Table 127. Smart Pharm Business Overview
Table 128. Smart Pharm Guaiphenesin Product
Table 129. Smart Pharm Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 130. Smart Pharm Recent Development
Table 131. Silarx Pharmaceuticals Company Detail
Table 132. Silarx Pharmaceuticals Business Overview
Table 133. Silarx Pharmaceuticals Guaiphenesin Product
Table 134. Silarx Pharmaceuticals Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 135. Silarx Pharmaceuticals Recent Development
Table 136. Meda Pharmaceuticals (Mylan) Company Detail
Table 137. Meda Pharmaceuticals (Mylan) Business Overview
Table 138. Meda Pharmaceuticals (Mylan) Guaiphenesin Product
Table 139. Meda Pharmaceuticals (Mylan) Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 140. Meda Pharmaceuticals (Mylan) Recent Development
Table 141. Aurohealth LLC Company Detail
Table 142. Aurohealth LLC Business Overview
Table 143. Aurohealth LLC Guaiphenesin Product
Table 144. Aurohealth LLC Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 145. Aurohealth LLC Recent Development
Table 146. Enzymatic Therapy Company Detail
Table 147. Enzymatic Therapy Business Overview
Table 148. Enzymatic Therapy Guaiphenesin Product
Table 149. Enzymatic Therapy Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 150. Enzymatic Therapy Recent Development
Table 151. Seven Star Pharma Company Detail
Table 152. Seven Star Pharma Business Overview
Table 153. Seven Star Pharma Guaiphenesin Product
Table 154. Seven Star Pharma Revenue in Guaiphenesin Business (2019-2024) & (US$ Million)
Table 155. Seven Star Pharma Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Guaiphenesin Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Guaiphenesin Market Share by Type: 2023 VS 2030
Figure 3. Active Pharmaceutical Ingredients Features
Figure 4. Preparation Features
Figure 5. Global Guaiphenesin Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Guaiphenesin Market Share by Application: 2023 VS 2030
Figure 7. Chronic Bronchitis With Phlegm Case Studies
Figure 8. Bronchiectasis Case Studies
Figure 9. Infection Case Studies
Figure 10. Other Case Studies
Figure 11. Guaiphenesin Report Years Considered
Figure 12. Global Guaiphenesin Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Guaiphenesin Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Guaiphenesin Market Share by Region: 2023 VS 2030
Figure 15. Global Guaiphenesin Market Share by Players in 2023
Figure 16. Global Top Guaiphenesin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guaiphenesin as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Guaiphenesin Revenue in 2023
Figure 18. North America Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Guaiphenesin Market Share by Country (2019-2030)
Figure 20. United States Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Guaiphenesin Market Share by Country (2019-2030)
Figure 24. Germany Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Guaiphenesin Market Share by Region (2019-2030)
Figure 32. China Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Guaiphenesin Market Share by Country (2019-2030)
Figure 40. Mexico Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Guaiphenesin Market Share by Country (2019-2030)
Figure 44. Turkey Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Guaiphenesin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. EMS Pharmaceutical Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 47. Mission Pharma Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 48. Orbis Biosciences Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 49. Sovereign Pharma Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 50. Lipocine Inc Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 51. Kowa Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 52. RB Pharma Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 53. Elan Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 54. Granules Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 55. Synthokem Labs Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 56. Haizhou Pharma Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 57. Prasco Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 58. Camlin Fine Science Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 59. Gennex Lab Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 60. Iwaki Seiyaku Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 61. Pan Drugs Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 62. Smart Pharm Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 63. Silarx Pharmaceuticals Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 64. Meda Pharmaceuticals (Mylan) Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 65. Aurohealth LLC Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 66. Enzymatic Therapy Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 67. Seven Star Pharma Revenue Growth Rate in Guaiphenesin Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
